Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis.
Bryan A VallejoAhmed AnsariSameer A ParikhSara J AchenbachKari G RabeAaron D NormanJanet E OlsonNeil E KayEsteban BraggioCurtis A HansonCeline M VachonJames R CerhanCristian L BaumTait D ShanafeltSusan L SlagerPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
LC-MBL is associated with an approximately two-fold increased risk of melanoma overall and a 2.74-fold increased risk of melanoma in situ.